The measurement and therapeutic implications of circulating tumour cells in breast cancer

por Smerage, J B, Hayes, D F
Publicado 2006

Elevated CA125 levels in patients with metastatic breast carcinoma.

por Perey, L., Hayes, D. F., Tondini, C., van Melle, G., Bauer, J., Lemarchand, T., Reymond, M., Mach, J. P., Leyvraz, S.
Publicado 1990

Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case–control study

por Henry, N L, Pchejetski, D, A'Hern, R, Nguyen, A T, Charles, P, Waxman, J, Li, L, Storniolo, A M, Hayes, D F, Flockhart, D A, Stearns, V, Stebbing, J
Publicado 2010

Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy

por Henry, N L, Nguyen, A, Azzouz, F, Li, L, Robarge, J, Philips, S, Cao, D, Skaar, T C, Rae, J M, Storniolo, A M, Flockhart, D A, Hayes, D F, Stearns, V
Publicado 2010

SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) r...

por Nahleh, Z. A., Barlow, W. E., Hayes, D. F., Schott, A. F., Gralow, J. R., Sikov, W. M., Perez, E. A., Chennuru, S., Mirshahidi, H. R., Corso, S. W., Lew, D. L., Pusztai, L., Livingston, R. B., Hortobagyi, G. N.
Publicado 2016

Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects

por Henry, N L, Chan, H-P, Dantzer, J, Goswami, C P, Li, L, Skaar, T C, Rae, J M, Desta, Z, Khouri, N, Pinsky, R, Oesterreich, S, Zhou, C, Hadjiiski, L, Philips, S, Robarge, J, Nguyen, A T, Storniolo, A M, Flockhart, D A, Hayes, D F, Helvie, M A, Stearns, V
Publicado 2013